Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7176
Planet Green Holdings
PLAG
$9.82M
| $7K | ﹤0.01% |
49
-106
| -68% | -$15.4K |
2016 Q3
2 quarters
|
|
|
CYTR
7177
PUT
DELISTED
CytRx Corp
CYTR
| $7K | ﹤0.01% |
+2,500
| New | +$6.33K |
2017 Q1
0 quarters
|
|
|
RTK
7178
DELISTED
Rentech, Inc.
RTK
| $7K | ﹤0.01% |
13,345
-4,362
| -25% | -$7.03K |
2016 Q3
2 quarters
|
|
|
GMO
7179
DELISTED
General Moly, Inc.
GMO
| $6K | ﹤0.01% |
12,971
-41,259
| -76% | -$19.8K |
2016 Q2
3 quarters
|
|
|
AVEO
7180
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $6K | ﹤0.01% |
+1,098
| New | +$7.93K |
2017 Q1
0 quarters
|
|
|
ANTH
7181
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $6K | ﹤0.01% |
1,850
-638
| -26% | -$3.02K |
2016 Q3
2 quarters
|
|
|
ANTH
7182
PUT
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $6K | ﹤0.01% |
1,875
-1,063
| -36% | -$5.03K |
2016 Q4
1 quarter
|
|
|
CYTR
7183
DELISTED
CytRx Corp
CYTR
| $6K | ﹤0.01% |
+2,121
| New | +$5.37K |
2017 Q1
0 quarters
|
|
|
ARGS
7184
CALL
DELISTED
Argos Therapeutics, Inc.
ARGS
| $6K | ﹤0.01% |
640
-390
| -38% | -$24.7K |
2016 Q3
2 quarters
|
|
|
KMI.WS
7185
DELISTED
Kinder Morgan Inc
KMI.WS
| $6K | ﹤0.01% |
2,711,056
+1,655,882
| +157% | +$7.12K |
2015 Q4
5 quarters
|
|
7186
CALL
Imunon
IMNN
$7.18M
| $5K | ﹤0.01% |
+6
| New | +$5.16K |
2017 Q1
0 quarters
|
|
7187
PEDEVCO
PED
$170M
| $5K | ﹤0.01% |
+268
| New | +$5.67K |
2017 Q1
0 quarters
|
|
|
ANTH
7188
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $5K | ﹤0.01% |
1,498
-28,176
| -95% | -$133K |
2016 Q2
3 quarters
|
|
|
GLOWE
7189
DELISTED
GLOWPOINT INC
GLOWE
| $3K | ﹤0.01% |
10,315
-102,239
| -91% | -$29.7K |
2014 Q3
10 quarters
|
|
7190
CALL
Savara
SVRA
$988M
| $1K | ﹤0.01% |
171
-53
| -24% | -$457 |
2016 Q1
4 quarters
|
|
7191
Ameris Bancorp
ABCB
$5.47B
| – | – |
-21,831
| Closed | -$952K | – |
|
7192
CALL
Abeona Therapeutics
ABEO
$288M
| – | – |
-432
| Closed | -$52K | – |
|
|
7193
Abeona Therapeutics
ABEO
$288M
| – | – |
-654
| Closed | -$79K | – |
|
7194
CALL
Asbury Automotive
ABG
$3.16B
| – | – |
-4,100
| Closed | -$253K | – |
|
|
7195
PUT
Asbury Automotive
ABG
$3.16B
| – | – |
-4,500
| Closed | -$278K | – |
|
7196
PUT
Arbutus Biopharma
ABUS
$882M
| – | – |
-37,500
| Closed | -$92K | – |
|
7197
CALL
Arch Capital
ACGL
$31.9B
| – | – |
-9,000
| Closed | -$259K | – |
|
|
7198
PUT
Arch Capital
ACGL
$31.9B
| – | – |
-14,700
| Closed | -$423K | – |
|
7199
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| – | – |
-51,459
| Closed | -$3.74M | – |
|
7200
iShares MSCI ACWI ex US ETF
ACWX
$17.6B
| – | – |
-103,940
| Closed | -$4.19M | – |
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.